These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 7741886)

  • 21. Short communication: The cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in Chaparral, Colombia in 2004.
    Vega JC; Sanchez BF; Montero LM; Montaña R; Del Pilar Mahecha M; Dueñes B; Baron AR; Reithinger R
    Trop Med Int Health; 2007 Dec; 12(12):1540-4. PubMed ID: 18076562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug regimens for visceral leishmaniasis in Mediterranean countries.
    Gradoni L; Soteriadou K; Louzir H; Dakkak A; Toz SO; Jaffe C; Dedet JP; Campino L; Cañavate C; Dujardin JC
    Trop Med Int Health; 2008 Oct; 13(10):1272-6. PubMed ID: 18764817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
    Kafetzis DA; Velissariou IM; Stabouli S; Mavrikou M; Delis D; Liapi G
    Int J Antimicrob Agents; 2005 Jan; 25(1):26-30. PubMed ID: 15620822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nephrotic syndrome and acute pancreatitis related to glucantime administration].
    Valencia ME; Laguna F; González Lahoz J
    An Med Interna; 2000 Jan; 17(1):54. PubMed ID: 10730416
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparative controlled trial of intralesionally-administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis.
    Sharquie KE; Najim RA; Farjou IB
    Clin Exp Dermatol; 1997 Jul; 22(4):169-73. PubMed ID: 9499605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of fluconazole on the pharmacokinetics and pharmacodynamics of antimony in cutaneous leishmaniasis-infected hamsters.
    Alnaim L; Abou Alsoud N; Zaghloul I; Al-Jaser M
    Int J Antimicrob Agents; 2007 Jun; 29(6):728-32. PubMed ID: 17369029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Miltefosine: oral treatment of leishmaniasis.
    Soto J; Soto P
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):177-85. PubMed ID: 16597200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic.
    Sundar S; More DK; Singh MK; Singh VP; Sharma S; Makharia A; Kumar PC; Murray HW
    Clin Infect Dis; 2000 Oct; 31(4):1104-7. PubMed ID: 11049798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biopsy-proven anuric acute tubular necrosis associated with vancomycin and one dose of aminoside.
    Sokol H; Vigneau C; Maury E; Guidet B; Offenstadt G
    Nephrol Dial Transplant; 2004 Jul; 19(7):1921-2. PubMed ID: 15199201
    [No Abstract]   [Full Text] [Related]  

  • 30. Complexation of antimony (Sb(V)) with guanosine 5'-monophosphate and guanosine 5'-diphospho-D-mannose: formation of both mono- and bis-adducts.
    Chai Y; Yan S; Wong IL; Chow LM; Sun H
    J Inorg Biochem; 2005 Dec; 99(12):2257-63. PubMed ID: 16214217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acute tubular necrosis caused by combination of diuretics in the treatment of several heart failure. A call to attention].
    de Luis DA; Liaño F; Pascual J; Ortuño J
    Rev Clin Esp; 1997 Aug; 197(8):592-3. PubMed ID: 9312802
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of American cutaneous leishmaniasis: a comparison between low dosage (5 mg/kg/day) and high dosage (20 mg/kg/day) antimony regimens.
    Oliveira-Neto MP; Schubach A; Mattos M; Gonçalves-Costa SC; Pirmez C
    Pathol Biol (Paris); 1997 Jun; 45(6):496-9. PubMed ID: 9309267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short report: efficacy of pentavalent antimony for treatment of colombian cutaneous leishmaniasis.
    Soto J; Toledo J; Vega J; Berman J
    Am J Trop Med Hyg; 2005 Apr; 72(4):421-2. PubMed ID: 15827279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute tubular necrosis after interleukin-2 therapy.
    Nzerue MC
    Cent Afr J Med; 1993 Sep; 39(9):195-6. PubMed ID: 8020090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 replication is stimulated by sodium stibogluconate, the therapeutic mainstay in the treatment of leishmaniasis.
    Barat C; Zhao C; Ouellette M; Tremblay MJ
    J Infect Dis; 2007 Jan; 195(2):236-45. PubMed ID: 17191169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimal change disease and acute tubular necrosis caused by diclofenac.
    Galesic K; Ljubanovic D; Bulimbasic S; Racic I
    Nephrology (Carlton); 2008 Feb; 13(1):87-8. PubMed ID: 18199110
    [No Abstract]   [Full Text] [Related]  

  • 37. Fatal stibocaptate toxicity.
    Rugemalila JB
    East Afr Med J; 1980 Oct; 57(10):720-2. PubMed ID: 6260456
    [No Abstract]   [Full Text] [Related]  

  • 38. Analysis of diseased and normal lung tissue for trace antimony content by neutron activation analysis.
    Kennedy JH
    Am J Med Sci; 1966 Jan; 251(1):37-9. PubMed ID: 5901111
    [No Abstract]   [Full Text] [Related]  

  • 39. Reactions Following the Administration of the Pentavalent Compounds of Antimony: An Analysis of Cases Reported by Several Correspondents.
    Napier LE
    Ind Med Gaz; 1926 Nov; 61(11):559-561. PubMed ID: 29011306
    [No Abstract]   [Full Text] [Related]  

  • 40. Toxicity of pentavalent antimony.
    Singh S; Sundar S
    J Assoc Physicians India; 1994 Sep; 42(9):755. PubMed ID: 7741886
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.